Melanocortin receptor ligands
US-2026085092-A1 · Mar 26, 2026 · US
derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/665 |
| Official title | derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin |
| Display label | derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin |
| Total patents | 35 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 5 |
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Neuropeptide-expressing vectors and methods for the treatment of epilepsy
US-2025034592-A1 · Jan 30, 2025 · US
Cyclotides in combination with kappa opioid receptor ligands for ms therapy
US-2024269230-A1 · Aug 15, 2024 · US
Bioconjugates of neuropeptides derivatives
US-11590232-B2 · Feb 28, 2023 · US
Melanocortin receptor ligands
US-2022127305-A1 · Apr 28, 2022 · US
Bioconjugates of neuropeptides derivatives
US-2021228724-A1 · Jul 29, 2021 · US
Neuropeptide-expressing vectors and methods for the treatment of epilepsy
US-2021108225-A1 · Apr 15, 2021 · US
Mu opioid receptor agonist analogs of the endomorphins
US-10919939-B2 · Feb 16, 2021 · US
Non-cytotoxic protein conjugates
US-10619146-B2 · Apr 14, 2020 · US
Melanocortin Receptor Ligands
US-2020095281-A1 · Mar 26, 2020 · US
Dynorphin A analogs with bradykinin receptors specificity for modulation of neuropathic pain
US-10428115-B2 · Oct 1, 2019 · US
Delta receptor agonist peptides and use thereof
US-10421785-B2 · Sep 24, 2019 · US
Methods and compositions related to improving properties of pharmacological agents targeting nervous system
US-2018340012-A1 · Nov 29, 2018 · US
Melanocortin Receptor Ligands
US-2018305406-A1 · Oct 25, 2018 · US
Mu opioid receptor agonist analogs of the endomorphins
US-2018222940-A1 · Aug 9, 2018 · US
Melanocortin Receptor Ligands
US-2018105557-A1 · Apr 19, 2018 · US
Mu opioid receptor agonist analogs of the endomorphins
US-2017369531-A1 · Dec 28, 2017 · US
Melanocortin receptor ligands
US-9850280-B2 · Dec 26, 2017 · US
Mu opioid receptor agonist analogs of the endomorphins
US-2017362276-A1 · Dec 21, 2017 · US
Delta receptor agonist peptides and use thereof
US-2017291922-A1 · Oct 12, 2017 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/665?
- CPC C07K14/665 is the Cooperative Patent Classification code for “derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin.”
- How many patents are filed under CPC C07K14/665 (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin)?
- Our database includes 35 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/665 growing?
- Publication counts under this code: 1 in 2024 vs 1 in 2025 (latest complete years).